UniProt ID | CHK2_HUMAN | |
---|---|---|
UniProt AC | O96017 | |
Protein Name | Serine/threonine-protein kinase Chk2 | |
Gene Name | CHEK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 543 | |
Subcellular Localization |
Isoform 2: Nucleus. Isoform 10 is present throughout the cell. Isoform 4: Nucleus. Isoform 7: Nucleus. Isoform 9: Nucleus. Isoform 12: Nucleus. Nucleus, PML body. Nucleus, nucleoplasm. Recruited into PML bodies together with TP53. |
|
Protein Description | Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition. [PubMed: 25361978] | |
Protein Sequence | MSRESDVEAQQSHGSSACSQPHGSVTQSQGSSSQSQGISSSSTSTMPNSSQSSHSSSGTLSSLETVSTQELYSIPEDQEPEDQEPEEPTPAPWARLWALQDGFANLECVNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAETTKRPAVCAAVL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MSRESDVEAQ -----CCCHHHHHHH | 46.25 | 29967540 | |
12 | Phosphorylation | SDVEAQQSHGSSACS HHHHHHHHHCCCCCC | 20.10 | 17918214 | |
15 | Phosphorylation | EAQQSHGSSACSQPH HHHHHHCCCCCCCCC | 14.89 | 17918214 | |
19 | Phosphorylation | SHGSSACSQPHGSVT HHCCCCCCCCCCCCC | 46.60 | 16205633 | |
24 | Phosphorylation | ACSQPHGSVTQSQGS CCCCCCCCCCCCCCC | 20.96 | 17918214 | |
26 | Phosphorylation | SQPHGSVTQSQGSSS CCCCCCCCCCCCCCC | 24.97 | 10973490 | |
28 | Phosphorylation | PHGSVTQSQGSSSQS CCCCCCCCCCCCCCC | 27.43 | 10973490 | |
33 | Phosphorylation | TQSQGSSSQSQGISS CCCCCCCCCCCCCCC | 35.23 | 20160490 | |
35 | Phosphorylation | SQGSSSQSQGISSSS CCCCCCCCCCCCCCC | 32.11 | 20160490 | |
39 | Phosphorylation | SSQSQGISSSSTSTM CCCCCCCCCCCCCCC | 30.87 | 17918214 | |
40 | Phosphorylation | SQSQGISSSSTSTMP CCCCCCCCCCCCCCC | 26.79 | 17918214 | |
41 | Phosphorylation | QSQGISSSSTSTMPN CCCCCCCCCCCCCCC | 30.74 | 17918214 | |
42 | Phosphorylation | SQGISSSSTSTMPNS CCCCCCCCCCCCCCC | 28.46 | 17918214 | |
43 | Phosphorylation | QGISSSSTSTMPNSS CCCCCCCCCCCCCCC | 30.11 | 17918214 | |
44 | Phosphorylation | GISSSSTSTMPNSSQ CCCCCCCCCCCCCCC | 25.34 | 17918214 | |
45 | Phosphorylation | ISSSSTSTMPNSSQS CCCCCCCCCCCCCCC | 36.41 | 17918214 | |
50 | Phosphorylation | TSTMPNSSQSSHSSS CCCCCCCCCCCCCCC | 40.50 | 10973490 | |
52 | Phosphorylation | TMPNSSQSSHSSSGT CCCCCCCCCCCCCCC | 31.78 | 17918214 | |
55 | Phosphorylation | NSSQSSHSSSGTLSS CCCCCCCCCCCCCCC | 28.31 | 17918214 | |
58 | Ubiquitination | QSSHSSSGTLSSLET CCCCCCCCCCCCEEE | 32.40 | 29967540 | |
62 | Phosphorylation | SSSGTLSSLETVSTQ CCCCCCCCEEEECHH | 33.08 | 16481012 | |
65 | Phosphorylation | GTLSSLETVSTQELY CCCCCEEEECHHHHC | 25.67 | 17918214 | |
66 | Ubiquitination | TLSSLETVSTQELYS CCCCEEEECHHHHCC | 4.21 | 29967540 | |
67 | Phosphorylation | LSSLETVSTQELYSI CCCEEEECHHHHCCC | 31.62 | 17918214 | |
68 | Phosphorylation | SSLETVSTQELYSIP CCEEEECHHHHCCCC | 23.02 | 21731742 | |
73 | Phosphorylation | VSTQELYSIPEDQEP ECHHHHCCCCCCCCC | 44.27 | 16481012 | |
119 | Ubiquitination | NYWFGRDKSCEYCFD CCEECCCCCCCEECC | 56.49 | 29967540 | |
120 | Phosphorylation | YWFGRDKSCEYCFDE CEECCCCCCCEECCC | 19.23 | 25159151 | |
123 | Phosphorylation | GRDKSCEYCFDEPLL CCCCCCCEECCCHHH | 11.62 | 27732954 | |
131 | Ubiquitination | CFDEPLLKRTDKYRT ECCCHHHHCCHHCCC | 62.02 | 29967540 | |
140 | Phosphorylation | TDKYRTYSKKHFRIF CHHCCCCCHHHHEEE | 34.32 | 18948271 | |
153 | Acetylation | IFREVGPKNSYIAYI EEHHHCCCCCEEEEE | 53.23 | 26051181 | |
163 (in isoform 9) | Phosphorylation | - | 25.47 | 24719451 | |
164 | Phosphorylation | IAYIEDHSGNGTFVN EEEEEECCCCCEEEE | 46.40 | 20126263 | |
174 | Ubiquitination | GTFVNTELVGKGKRR CEEEECEECCCCCCC | 6.07 | 29967540 | |
174 (in isoform 9) | Ubiquitination | - | 6.07 | - | |
192 | Phosphorylation | NNSEIALSLSRNKVF CCCHHEEEECCCCEE | 18.44 | 24719451 | |
194 | Phosphorylation | SEIALSLSRNKVFVF CHHEEEECCCCEEEE | 30.36 | 17081983 | |
204 (in isoform 2) | Phosphorylation | - | 4.20 | 20049867 | |
205 | Phosphorylation | VFVFFDLTVDDQSVY EEEEEEEECCCCCCC | 24.59 | 20126263 | |
210 | Phosphorylation | DLTVDDQSVYPKALR EEECCCCCCCCHHHH | 30.52 | 20126263 | |
223 | Ubiquitination | LRDEYIMSKTLGSGA HHCHHHHHCCCCCCC | 16.96 | 29967540 | |
224 | Ubiquitination | RDEYIMSKTLGSGAC HCHHHHHCCCCCCCC | 30.32 | 29967540 | |
225 | Phosphorylation | DEYIMSKTLGSGACG CHHHHHCCCCCCCCC | 29.10 | 25056879 | |
235 | Acetylation | SGACGEVKLAFERKT CCCCCHHHHHHCCCC | 29.78 | 30587659 | |
237 | Ubiquitination | ACGEVKLAFERKTCK CCCHHHHHHCCCCCC | 9.87 | 29967540 | |
251 | Ubiquitination | KKVAIKIISKRKFAI CHHHHHHHHCCCEEE | 3.18 | 29967540 | |
260 | Phosphorylation | KRKFAIGSAREADPA CCCEEECCCCCCCCC | 20.31 | 28355574 | |
267 | Ubiquitination | SAREADPALNVETEI CCCCCCCCCCHHHHH | 16.59 | 29967540 | |
267 (in isoform 9) | Ubiquitination | - | 16.59 | - | |
273 | Ubiquitination | PALNVETEIEILKKL CCCCHHHHHHHHHHC | 25.72 | 29967540 | |
279 | Ubiquitination | TEIEILKKLNHPCII HHHHHHHHCCCCEEE | 51.59 | 29967540 | |
287 | Ubiquitination | LNHPCIIKIKNFFDA CCCCEEEEEECCCCH | 27.93 | 29967540 | |
303 (in isoform 9) | Phosphorylation | - | 3.11 | 24719451 | |
322 | Ubiquitination | GNKRLKEATCKLYFY CCHHHHHHHHHHHHH | 19.40 | 29967540 | |
327 | Phosphorylation | KEATCKLYFYQMLLA HHHHHHHHHHHHHHH | 5.92 | 24043423 | |
329 | Phosphorylation | ATCKLYFYQMLLAVQ HHHHHHHHHHHHHHH | 4.58 | 24043423 | |
330 | Ubiquitination | TCKLYFYQMLLAVQY HHHHHHHHHHHHHHH | 13.22 | 29967540 | |
337 | Phosphorylation | QMLLAVQYLHENGII HHHHHHHHHHHCCCC | 11.92 | 24043423 | |
350 (in isoform 12) | Phosphorylation | - | 45.77 | 29507054 | |
356 | Phosphorylation | KPENVLLSSQEEDCL CHHHEEECCCCCCCE | 26.30 | 20873877 | |
357 | Phosphorylation | PENVLLSSQEEDCLI HHHEEECCCCCCCEE | 41.39 | 20873877 | |
372 | Phosphorylation | KITDFGHSKILGETS EEECCCCCHHCCCHH | 23.05 | 20713355 | |
373 | Ubiquitination | ITDFGHSKILGETSL EECCCCCHHCCCHHH | 35.95 | - | |
378 | Phosphorylation | HSKILGETSLMRTLC CCHHCCCHHHHHHHH | 25.92 | 17698850 | |
379 | Phosphorylation | SKILGETSLMRTLCG CHHCCCHHHHHHHHC | 18.83 | 28355574 | |
381 | Sulfoxidation | ILGETSLMRTLCGTP HCCCHHHHHHHHCCC | 2.85 | 21406390 | |
383 | Phosphorylation | GETSLMRTLCGTPTY CCHHHHHHHHCCCCC | 16.66 | 17698850 | |
387 | Phosphorylation | LMRTLCGTPTYLAPE HHHHHHCCCCCCCCE | 16.09 | 30278072 | |
389 | Phosphorylation | RTLCGTPTYLAPEVL HHHHCCCCCCCCEEE | 30.88 | 28464451 | |
390 | Phosphorylation | TLCGTPTYLAPEVLV HHHCCCCCCCCEEEE | 11.32 | 28464451 | |
401 | Phosphorylation | EVLVSVGTAGYNRAV EEEEEECCCCCCHHH | 18.11 | 22210691 | |
415 | Ubiquitination | VDCWSLGVILFICLS HHHHHHHHHHHHHHH | 4.10 | 29967540 | |
416 (in isoform 9) | Ubiquitination | - | 2.17 | - | |
429 | Ubiquitination | SGYPPFSEHRTQVSL HCCCCCCCCCCCCCH | 37.46 | 29967540 | |
430 (in isoform 9) | Phosphorylation | - | 36.57 | 24719451 | |
432 | Phosphorylation | PPFSEHRTQVSLKDQ CCCCCCCCCCCHHHH | 34.92 | 15213307 | |
435 | Phosphorylation | SEHRTQVSLKDQITS CCCCCCCCHHHHHHC | 21.64 | 18538787 | |
437 | Ubiquitination | HRTQVSLKDQITSGK CCCCCCHHHHHHCCC | 39.83 | - | |
441 | Phosphorylation | VSLKDQITSGKYNFI CCHHHHHHCCCCCCC | 26.29 | 23403867 | |
442 | Phosphorylation | SLKDQITSGKYNFIP CHHHHHHCCCCCCCH | 34.61 | 23403867 | |
443 | Ubiquitination | LKDQITSGKYNFIPE HHHHHHCCCCCCCHH | 28.02 | 29967540 | |
444 | Ubiquitination | KDQITSGKYNFIPEV HHHHHCCCCCCCHHH | 36.47 | 29967540 | |
456 | Phosphorylation | PEVWAEVSEKALDLV HHHHHHHHHHHHHHH | 25.53 | 15535844 | |
458 | Ubiquitination | VWAEVSEKALDLVKK HHHHHHHHHHHHHHH | 46.90 | 29967540 | |
465 | Ubiquitination | KALDLVKKLLVVDPK HHHHHHHHHCCCCCC | 39.30 | 29967540 | |
472 | Ubiquitination | KLLVVDPKARFTTEE HHCCCCCCCCCCHHH | 47.97 | 29967540 | |
478 (in isoform 9) | Phosphorylation | - | 37.91 | 24719451 | |
480 (in isoform 9) | Ubiquitination | - | 12.03 | - | |
487 | Ubiquitination | ALRHPWLQDEDMKRK HHHCCCCCCHHHHHH | 48.45 | 29967540 | |
494 | Ubiquitination | QDEDMKRKFQDLLSE CCHHHHHHHHHHHHH | 41.69 | 29967540 | |
500 | Phosphorylation | RKFQDLLSEENESTA HHHHHHHHHCCCCCC | 50.60 | 23312004 | |
501 | Ubiquitination | KFQDLLSEENESTAL HHHHHHHHCCCCCCH | 65.88 | 29967540 | |
505 | Phosphorylation | LLSEENESTALPQVL HHHHCCCCCCHHHHH | 30.48 | 22210691 | |
506 | Phosphorylation | LSEENESTALPQVLA HHHCCCCCCHHHHHC | 26.49 | 22210691 | |
508 (in isoform 9) | Ubiquitination | - | 2.86 | - | |
515 | Ubiquitination | LPQVLAQPSTSRKRP HHHHHCCCCCCCCCC | 33.69 | 29967540 | |
516 | Phosphorylation | PQVLAQPSTSRKRPR HHHHCCCCCCCCCCC | 27.25 | 25159151 | |
517 | Phosphorylation | QVLAQPSTSRKRPRE HHHCCCCCCCCCCCC | 38.95 | 25159151 | |
518 | Phosphorylation | VLAQPSTSRKRPREG HHCCCCCCCCCCCCC | 39.89 | 25850435 | |
537 | Ubiquitination | AETTKRPAVCAAVL- CCCCCCCCCEEEEC- | 17.04 | 29967540 | |
537 (in isoform 9) | Ubiquitination | - | 17.04 | - | |
559 (in isoform 9) | Phosphorylation | - | 24719451 | ||
560 (in isoform 9) | Phosphorylation | - | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
19 | S | Phosphorylation | Kinase | ATM | Q13315 | PhosphoELM |
19 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
26 | T | Phosphorylation | Kinase | ATM | Q13315 | PSP |
26 | T | Phosphorylation | Kinase | PLK1 | P53350 | PhosphoELM |
28 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
33 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
33 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
35 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
35 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
50 | S | Phosphorylation | Kinase | ATM | Q13315 | PhosphoELM |
62 | S | Phosphorylation | Kinase | PLK3 | Q9H4B4 | Uniprot |
68 | T | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
68 | T | Phosphorylation | Kinase | TTK | P33981 | PSP |
68 | T | Phosphorylation | Kinase | ZAK | Q9NYL2 | PSP |
68 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
68 | T | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
68 | T | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
68 | T | Phosphorylation | Kinase | ATR | Q13535 | PSP |
73 | S | Phosphorylation | Kinase | PLK3 | Q9H4B4 | Uniprot |
120 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
140 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
164 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
205 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
210 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
225 | T | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
260 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
379 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
383 | T | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
383 | T | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
387 | T | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
387 | T | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
432 | T | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
435 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
516 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF8 | O76064 | PMID:22266820 |
- | K | Ubiquitination | E3 ubiquitin ligase | RCHY1 | Q96PM5 | PMID:23449389 |
- | K | Ubiquitination | E3 ubiquitin ligase | SIAH2 | O43255 | PMID:26751770 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
153 | Acetylation | 157 (4) | I ⇒ T | rs17879961 |
| 24880342 29059683 |
loading...
Phosphorylation | |
Reference | PubMed |
"Regulation of Chk2 ubiquitination and signaling throughautophosphorylation of serine 379."; Lovly C.M., Yan L., Ryan C.E., Takada S., Piwnica-Worms H.; Mol. Cell. Biol. 28:5874-5885(2008). Cited for: FUNCTION IN APOPTOSIS, AUTOPHOSPHORYLATION AT SER-379, MUTAGENESIS OFSER-379, UBIQUITINATION, AND INTERACTION WITH CUL1. | |
"Stability of checkpoint kinase 2 is regulated via phosphorylation atserine 456."; Kass E.M., Ahn J., Tanaka T., Freed-Pastor W.A., Keezer S., Prives C.; J. Biol. Chem. 282:30311-30321(2007). Cited for: FUNCTION IN APOPTOSIS, PHOSPHORYLATION AT SER-456, UBIQUITINATION, ANDMUTAGENESIS OF SER-456. | |
"Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediatesits full activation by ATM and a downstream checkpoint in response toDNA damage."; Bahassi el M., Myer D.L., McKenney R.J., Hennigan R.F.,Stambrook P.J.; Mutat. Res. 596:166-176(2006). Cited for: PHOSPHORYLATION AT SER-62; THR-68 AND SER-73, AND MUTAGENESIS OFSER-73. | |
"Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1phosphatase."; Fujimoto H., Onishi N., Kato N., Takekawa M., Xu X.Z., Kosugi A.,Kondo T., Imamura M., Oishi I., Yoda A., Minami Y.; Cell Death Differ. 13:1170-1180(2006). Cited for: PHOSPHORYLATION AT THR-68, AND DEPHOSPHORYLATION AT THR-68 BY PPM1D. | |
"The stress kinase MRK contributes to regulation of DNA damagecheckpoints through a p38gamma-independent pathway."; Tosti E., Waldbaum L., Warshaw G., Gross E.A., Ruggieri R.; J. Biol. Chem. 279:47652-47660(2004). Cited for: ENZYME REGULATION, PHOSPHORYLATION AT THR-68 BY MLTK, AND MUTAGENESISOF THR-68 AND ASP-368. | |
"The hCds1 (Chk2)-FHA domain is essential for a chain ofphosphorylation events on hCds1 that is induced by ionizingradiation."; Lee C.H., Chung J.H.; J. Biol. Chem. 276:30537-30541(2001). Cited for: AUTOPHOSPHORYLATION AT THR-383 AND THR-387, AND MUTAGENESIS OF THR-383AND THR-387. |